{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T00:09:01Z","timestamp":1785802141676,"version":"3.56.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T00:00:00Z","timestamp":1519171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cancer and heart failure (HF) are common medical conditions with a steadily rising prevalence in industrialized countries, particularly in the elderly, and they both potentially carry a poor prognosis. A new diagnosis of malignancy in subjects with pre-existing HF is not infrequent, and challenges HF specialists as well as oncologists with complex questions relating to both HF and cancer management. An increased incidence of cancer in patients with established HF has also been suggested. This review paper summarizes the epidemiology and the prognostic implications of cancer occurrence in HF, the impact of pre-existing HF on cancer treatment decisions and the impact of cancer on HF therapeutic options, while providing some practical suggestions regarding patient care and highlighting gaps in knowledge.<\/jats:p>","DOI":"10.1002\/ejhf.1165","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T15:29:42Z","timestamp":1519226982000},"page":"879-887","source":"Crossref","is-referenced-by-count":172,"title":["Cancer Diagnosis in Patients with Heart Failure: Epidemiology, Clinical Implications and Gaps in Knowledge"],"prefix":"10.1093","volume":"20","author":[{"given":"Pietro","family":"Ameri","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, University of Genova; and Cardiology Unit, IRCCS Policlinic Hospital San Martino , Genova ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Canepa","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Genova; and Cardiology Unit, IRCCS Policlinic Hospital San Martino , Genova ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus S.","family":"Anker","sequence":"additional","affiliation":[{"name":"Department of Cardiology (CBF), Charit\u00e9 University Medicine, Berlin, Germany; AND Division of Cardiology and Metabolism - Heart Failure, Cachexia & Sarcopenia; Department of Internal Medicine & Cardiology; and Berlin-Brandenburg Center for Regenerative Therapies (BCRT), at Charit\u00e9 University Medicine , Berlin ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury","family":"Belenkov","sequence":"additional","affiliation":[{"name":"Cardiology Research Institute , Moscow ,","place":["Russia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jutta","family":"Bergler-Klein","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Medical University of Vienna , Vienna ,","place":["Austria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Cohen-Solal","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Lariboisi\u00e8re Hospital, Paris, France; U942 INSERM, BIOCANVAS (Biomarqueurs Cardiovasculaires), Paris, France;, Department of Cardiology, University of Paris VII Denis Diderot , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Farmakis","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Clinic, Heart Failure Unit, Department of Cardiology, Athens University Hospital \u2018Attikon\u2019, National and Kapodistrian University of Athens , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"L\u00f3pez-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Unit, Cardiac Imaging Unit, Department of Cardiology, La Paz University Hospital, IdiPAz , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitja","family":"Lainscak","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Department of Research and Education, General Hospital Celje, Celje, Slovenia, Faculty of Medicine, University of Ljubljana , Ljubljana ,","place":["Slovenia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radek","family":"Pudil","sequence":"additional","affiliation":[{"name":"1st Department of Medicine - Cardioangiology, Medical Faculty and University Hospital Hradec Kralove \u00a0","place":["Czech Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ruschitska","sequence":"additional","affiliation":[{"name":"University Heart Center, University Hospital Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petar","family":"Seferovic","sequence":"additional","affiliation":[{"name":"Belgrade University Medical Center , Belgrade ,","place":["Serbia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Clinic, Heart Failure Unit, Department of Cardiology, Athens University Hospital \u2018Attikon\u2019, National and Kapodistrian University of Athens , Athens ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Coats","sequence":"additional","affiliation":[{"name":"Monash University, Australia and University of Warwick \u00a0","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Suter","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Cardio-Oncology, Bern University Hospital , Bern ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Von Haehling","sequence":"additional","affiliation":[{"name":"Klinik f\u00fcr Kardiologie und Pneumologie, Herzzentrum G\u00f6ttingen, Universit\u00e4tsmedizin G\u00f6ttingen, Georg-August-Universit\u00e4t, G\u00f6ttingen, Germany;, Deutsches Zentrum f\u00fcr Herz- und Kreislaufforschung, Standort G\u00f6ttingen , G\u00f6ttingen ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fortunato","family":"Ciardiello","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Medicine \u201cFlaviano Magrassi\u201d, Luigi Vanvitelli University of Campania , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf A.","family":"de Boer","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University of Groningen, University Medical Center Groningen , Groningen ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander R.","family":"Lyon","sequence":"additional","affiliation":[{"name":"Royal Brompton Hospital and Imperial College London \u00a0","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo G.","family":"Tocchetti","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, Federico II University , Naples ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the Heart Failure Association Cardio-Oncology Study Group of the European Society of Cardiology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,2,21]]},"reference":[{"key":"2026011721235096600_ejhf1165-bib-0001","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0002","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ejhf.567","article-title":"Heart failure epidemiology 2000\u20132013: insights from the German Federal Health Monitoring System","volume":"18","author":"Christ","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0003","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2005.062026","article-title":"Epidemiology and management of heart failure and left ventricular systolic dysfunction in the aftermath of a myocardial infarction","volume":"91","author":"Cleland","year":"2005","journal-title":"Heart"},{"key":"2026011721235096600_ejhf1165-bib-0004","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2174\/1573403X11309020005","article-title":"Heart failure epidemiology: European perspective","volume":"9","author":"Guha","year":"2013","journal-title":"Curr Cardiol Rev"},{"key":"2026011721235096600_ejhf1165-bib-0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/carcin\/bgv100","article-title":"Unraveling the links between cancer and aging","volume":"37","author":"Serrano","year":"2016","journal-title":"Carcinogenesis"},{"key":"2026011721235096600_ejhf1165-bib-0006","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"2026011721235096600_ejhf1165-bib-0007","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jacc.2013.04.088","article-title":"Patients with heart failure have an increased risk of incident cancer","volume":"62","author":"Hasin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026011721235096600_ejhf1165-bib-0008","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2016.04.053","article-title":"Heart failure after myocardial infarction is associated with increased risk of cancer","volume":"68","author":"Hasin","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026011721235096600_ejhf1165-bib-0009","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ejhf.472","article-title":"Incidence of cancer in patients with chronic heart failure: a long-term follow-up study","volume":"18","author":"Banke","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0010","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","author":"Mentz","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026011721235096600_ejhf1165-bib-0011","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Albini","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"2026011721235096600_ejhf1165-bib-0012","first-page":"175","article-title":"The symptoms of advanced cancer: relationship to age, gender, and performance status in 1000 patients","volume":"8","author":"Walsh","year":"2000","journal-title":"Support Care Cancer"},{"key":"2026011721235096600_ejhf1165-bib-0013","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/eurjhf\/hfp007","article-title":"A comparative study of the palliative care needs of heart failure and cancer patients","volume":"11","author":"O'Leary","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0014","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1042\/CS20160412","article-title":"An emerging epidemic: cancer and heart failure","volume":"131","author":"Thavendiranathan","year":"2017","journal-title":"Clin Sci (Lond)"},{"key":"2026011721235096600_ejhf1165-bib-0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ijcard.2015.10.172","article-title":"The medical and socioeconomic burden of heart failure: a comparative delineation with cancer","volume":"203","author":"Farmakis","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026011721235096600_ejhf1165-bib-0016","doi-asserted-by":"crossref","first-page":"10634","DOI":"10.1038\/ncomms10634","article-title":"Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination","volume":"7","author":"Le","year":"2016","journal-title":"Nat Commun"},{"key":"2026011721235096600_ejhf1165-bib-0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1172\/JCI16645","article-title":"Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth","volume":"112","author":"Egami","year":"2003","journal-title":"J Clin Invest"},{"key":"2026011721235096600_ejhf1165-bib-0018","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1470-2045(10)70106-6","article-title":"Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials","volume":"11","author":"Sipahi","year":"2010","journal-title":"Lancet Oncol"},{"key":"2026011721235096600_ejhf1165-bib-0019","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/bcr3386","article-title":"Breast cancer in women using digoxin: tumor characteristics and relapse risk","volume":"15","author":"Biggar","year":"2013","journal-title":"Breast Cancer Res"},{"key":"2026011721235096600_ejhf1165-bib-0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1470-2045(10)70260-6","article-title":"Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials","volume":"12","author":"Bangalore","year":"2011","journal-title":"Lancet Oncol"},{"key":"2026011721235096600_ejhf1165-bib-0021","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10549-014-3058-8","article-title":"Cardiac glycosides and the risk of breast cancer in women with chronic heart failure and supraventricular arrhythmia","volume":"146","author":"Couraud","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"2026011721235096600_ejhf1165-bib-0022","first-page":"741","article-title":"Critical review of cancer risk associated with angiotensin receptor blocker therapy","volume":"7","author":"Wuerzner","year":"2011","journal-title":"Vasc Health Risk Manag"},{"key":"2026011721235096600_ejhf1165-bib-0023","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1158\/1078-0432.CCR-14-2332","article-title":"Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma","volume":"21","author":"McKay","year":"2015","journal-title":"Clin Cancer Res"},{"key":"2026011721235096600_ejhf1165-bib-0024","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00432-016-2278-1","article-title":"Beta-adrenergic modulation of cancer cell proliferation: available evidence and clinical perspectives","volume":"143","author":"Coelho","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"2026011721235096600_ejhf1165-bib-0025","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/cvr\/cvv274","article-title":"Bidirectional cross-regulation between ErbB2 and beta-adrenergic signalling pathways","volume":"109","author":"Sysa-Shah","year":"2016","journal-title":"Cardiovasc Res"},{"key":"2026011721235096600_ejhf1165-bib-0026","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1200\/JCO.2010.33.5422","article-title":"beta blockers and breast cancer mortality: a population-based study","volume":"29","author":"Barron","year":"2011","journal-title":"J Clin Oncol"},{"key":"2026011721235096600_ejhf1165-bib-0027","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ijc.30526","article-title":"Effects of statins on cancer mortality and progression: a systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals","volume":"140","author":"Mei","year":"2017","journal-title":"Int J Cancer"},{"key":"2026011721235096600_ejhf1165-bib-0028","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/ejhf.822","article-title":"Do patients have worse outcomes in heart failure than in cancer? A primary care-based cohort study with 10-year follow-up in Scotland","volume":"19","author":"Mamas","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0029","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/ejhf.617","article-title":"National trends in heart failure hospitalization rates in Slovenia 2004\u20132012","volume":"18","author":"Omersa","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0030","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2014.07.948","article-title":"Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer","volume":"64","author":"Cramer","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026011721235096600_ejhf1165-bib-0031","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jacc.2013.11.026","article-title":"Insights into onco-cardiology: atrial fibrillation in cancer","volume":"63","author":"Farmakis","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026011721235096600_ejhf1165-bib-0032","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1002\/ejhf.670","article-title":"Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study","volume":"18","author":"Anker","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0033","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.lungcan.2015.01.006","article-title":"Cardiovascular comorbidities and survival of lung cancer patients: Medicare data based analysis","volume":"88","author":"Kravchenko","year":"2015","journal-title":"Lung Cancer"},{"key":"2026011721235096600_ejhf1165-bib-0034","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/ejhf.654","article-title":"2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)","volume":"19","author":"Zamorano","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0035","doi-asserted-by":"crossref","first-page":"e002661","DOI":"10.1161\/CIRCHEARTFAILURE.115.002661","article-title":"Cancer therapy-related cardiac dysfunction and heart failure: part 1: definitions, pathophysiology, risk factors, and imaging","volume":"9","author":"Bloom","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0036","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.cardfail.2016.04.008","article-title":"Models of heart failure based on the cardiotoxicity of anticancer drugs","volume":"22","author":"Mercurio","year":"2016","journal-title":"J Card Fail"},{"key":"2026011721235096600_ejhf1165-bib-0037","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2016.11.174","article-title":"Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond","volume":"227","author":"Di Lisi","year":"2017","journal-title":"Int J Cardiol"},{"key":"2026011721235096600_ejhf1165-bib-0038","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.eururo.2014.11.039","article-title":"Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis","volume":"68","author":"Bosco","year":"2015","journal-title":"Eur Urol"},{"key":"2026011721235096600_ejhf1165-bib-0039","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/11594540-000000000-00000","article-title":"Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care","volume":"34","author":"Martin-Merino","year":"2011","journal-title":"Drug Saf"},{"key":"2026011721235096600_ejhf1165-bib-0040","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1001\/jamaoncol.2016.1726","article-title":"Angiotensin II-receptor inhibition with candesartan to prevent trastuzumab-related cardiotoxic effects in patients with early breast cancer: a randomized clinical trial","volume":"2","author":"Boekhout","year":"2016","journal-title":"JAMA Oncol"},{"key":"2026011721235096600_ejhf1165-bib-0041","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1093\/eurheartj\/ehw022","article-title":"Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 x 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol","volume":"37","author":"Gulati","year":"2016","journal-title":"Eur Heart J"},{"key":"2026011721235096600_ejhf1165-bib-0042","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.yjmcc.2004.05.024","article-title":"Carvedilol prevents doxorubicin-induced free radical release and apoptosis in cardiomyocytes in vitro","volume":"37","author":"Spallarossa","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"2026011721235096600_ejhf1165-bib-0043","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000448166","article-title":"Prevalence and prognostic impact of chronic obstructive pulmonary disease in patients with chronic heart failure: data from the GISSI-HF trial","volume":"136","author":"Canepa","year":"2017","journal-title":"Cardiology"},{"key":"2026011721235096600_ejhf1165-bib-0044","article-title":"ESC-HFA Heart Failure Long-Term Registry Investigators. Characteristics, treatments and 1-year prognosis of hospitalized and ambulatory heart failure patients with chronic obstructive pulmonary disease in the European Society of Cardiology Heart Failure Long-Term Registry","author":"Canepa","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0045","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ijcard.2016.09.063","article-title":"Depression in heart failure: intricate relationship, pathophysiology and most updated evidence of interventions from recent clinical studies","volume":"224","author":"Ghosh","year":"2016","journal-title":"Int J Cardiol"},{"key":"2026011721235096600_ejhf1165-bib-0046","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1001\/jamainternmed.2015.5220","article-title":"Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial","volume":"175","author":"Freedland","year":"2015","journal-title":"JAMA Intern Med"},{"key":"2026011721235096600_ejhf1165-bib-0047","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1093\/ehjci\/jew190","article-title":"The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"17","author":"Lancellotti","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026011721235096600_ejhf1165-bib-0048","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/eurheartj\/ehs181","article-title":"Cancer drugs and the heart: importance and management","volume":"34","author":"Suter","year":"2013","journal-title":"Eur Heart J"},{"key":"2026011721235096600_ejhf1165-bib-0049","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.781","article-title":"Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry","volume":"19","author":"Lund","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0050","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cardfail.2016.04.003","article-title":"The utility of point-of-care biomarkers to detect cardiotoxicity during anthracycline chemotherapy: a feasibility study","volume":"22","author":"Lenihan","year":"2016","journal-title":"J Card Fail"},{"key":"2026011721235096600_ejhf1165-bib-0051","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1442-2042.2012.03033.x","article-title":"Therapy management of cardiovascular adverse events in the context of targeted therapy for metastatic renal cell carcinoma","volume":"19","author":"Schmidinger","year":"2012","journal-title":"Int J Urol"},{"key":"2026011721235096600_ejhf1165-bib-0052","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11886-016-0730-0","article-title":"Arrhythmias and other electrophysiology issues in cancer patients receiving chemotherapy or radiation","volume":"18","author":"Viganego","year":"2016","journal-title":"Curr Cardiol Rep"},{"key":"2026011721235096600_ejhf1165-bib-0053","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1093\/ehjci\/jet123","article-title":"European Society of Cardiology Working Groups on Nuclear Ccardiology and Cardiac Computed Tomography and Cardiovascular Magnetic Resonance; American Society of Nuclear Cardiology; Society for Cardiovascular Magnetic Resonance; Society of Cardiovascular Computed Tomography. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography","volume":"14","author":"Lancellotti","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026011721235096600_ejhf1165-bib-0054","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1002\/cncr.22726","article-title":"The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer","volume":"109","author":"Gross","year":"2007","journal-title":"Cancer"},{"key":"2026011721235096600_ejhf1165-bib-0055","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/cvr\/cvx078","article-title":"Inhibition of the cardiac myocyte mineralocorticoid receptor ameliorates doxorubicin-induced cardiotoxicity","volume":"114","author":"Lother","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2026011721235096600_ejhf1165-bib-0056","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"2026011721235096600_ejhf1165-bib-0057","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"key":"2026011721235096600_ejhf1165-bib-0058","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jchf.2016.07.012","article-title":"Efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation and heart failure: a meta-analysis","volume":"4","author":"Savarese","year":"2016","journal-title":"JACC Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0059","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(16)30369-2","article-title":"International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"17","author":"Farge","year":"2016","journal-title":"Lancet Oncol"},{"key":"2026011721235096600_ejhf1165-bib-0060","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/ejhf.685","article-title":"The impact of co-morbidity burden on appropriate implantable cardioverter defibrillator therapy and all-cause mortality: insight from Danish nationwide clinical registers","volume":"19","author":"Ruwald","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0061","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"International Society for Heart and Lung Transplantation. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"2026011721235096600_ejhf1165-bib-0062","doi-asserted-by":"crossref","first-page":"e002800","DOI":"10.1161\/CIRCHEARTFAILURE.115.002800","article-title":"Frequency of poor outcome (death or poor quality of life) after left ventricular assist device for destination therapy: results from the INTERMACS registry","volume":"9","author":"Arnold","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2026011721235096600_ejhf1165-bib-0063","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.healun.2012.09.007","article-title":"Long-term follow-up of lung and heart transplant recipients with pre-transplant malignancies","volume":"31","author":"Sigurdardottir","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"2026011721235096600_ejhf1165-bib-0064","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1136\/heartjnl-2011-300048","article-title":"UK guidelines for referral and assessment of adults for heart transplantation","volume":"97","author":"Banner","year":"2011","journal-title":"Heart"},{"key":"2026011721235096600_ejhf1165-bib-0065","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/ejcts\/ezv203","article-title":"A difficult decision: what should we do when malignant tumours are diagnosed in patients supported by left ventricular assist devices?","volume":"48","author":"Smail","year":"2015","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026011721235096600_ejhf1165-bib-0066","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2459\/JCM.0000000000000216","article-title":"Double organ transplantation in cardiac amyloidosis","volume":"17","author":"Gkouziouta","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"2026011721235096600_ejhf1165-bib-0067","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1634\/theoncologist.2016-0412","article-title":"SAFE-HEaRt: rationale and design of a pilot study investigating cardiac safety of HER2 targeted therapy in patients with HER2-positive breast cancer and reduced left ventricular function","volume":"22","author":"Lynce","year":"2017","journal-title":"Oncologist"}],"container-title":["European Journal of Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fejhf.1165","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/20\/5\/879\/66269295\/eurjhf_20_5_879.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjhf\/article-pdf\/20\/5\/879\/66269295\/eurjhf_20_5_879.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:26:23Z","timestamp":1768703183000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjhf\/article\/20\/5\/879\/8414719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,21]]},"references-count":67,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,2,21]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ejhf.1165","relation":{},"ISSN":["1388-9842","1879-0844"],"issn-type":[{"value":"1388-9842","type":"print"},{"value":"1879-0844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,2,21]]}}}